A retrospective study among 58 controls and 349 patients with biopsy-proven NAFLD explored the diagnostic accuracy of noninvasive testing stratified by PNPLA3 genotype [64]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.